The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

Recent use of non-vitamin K antagonist oral anticoagulants (NOACs) is not associated with increased risk for bleeding following treatment with intravenous alteplase for ischemic stroke, new data ...

Despite the potential benefits, health practitioners should be aware of the risks associated with thrombolytic therapy. A meta-analysis evaluating outcomes with the use of thrombolytic therapy ...

SAN DIEGO, CA—Percutaneous mechanical thrombectomy that avoids use of thrombolytic therapy can improve RV/LV ratio in patients with pulmonary embolism (PE), according to results of the FLARE study. At ...

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...

ATS 2011, DENVER – Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S.

The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...